Suppr超能文献

腹腔镜与开腹肝切除术治疗巨大肝细胞癌(≥10cm):来自高容量转诊中心的回顾性分析。

Laparoscopic versus open liver resection for huge hepatocellular carcinoma (≥ than 10 cm): a retrospective analysis from a high-volume referral center.

机构信息

Department of Clinical Medicine and Surgery, Division of HBP Minimally Invasive and Robotic Surgery, Transplantation Service, Federico II University Hospital, Naples, Italy.

Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seoul, South Korea.

出版信息

Surg Endosc. 2024 Nov;38(11):6324-6331. doi: 10.1007/s00464-024-11091-4. Epub 2024 Aug 27.

Abstract

BACKGROUND

There is still poor evidence about the safety and feasibility of laparoscopic liver resection (LLR) for huge (> 10 cm) hepatocellular carcinomas (HCC). The aim of this study was to assess the short- and long-term outcomes of LLR versus open liver resection (OLR) for patients with huge HCC from real-life data from consecutive patients.

METHODS

Data regarding all consecutive patients undergoing liver resection for huge HCC were retrospectively collected from a Korean referral HPB center. Primary outcomes were the postoperative results, while secondary outcomes were the oncologic survivals.

RESULTS

Sixty-three patients were included in the study: 46 undergoing OLR and 17 LLR. Regarding postoperative outcomes, there were no statistically significant differences in estimated blood loss, operation time, transfusions, postoperative bile leak, ascites, severe complications, and R1 resection rates. After a median follow-up of 48.4 (95% CI 8.9-86.8) months, there were no statistically significant differences in 3 years OS (59.3 ± 8.7 months vs. 85.2 ± 9.8 months) and 5 years OS (31.1 ± 9 months vs. 73.1 ± 14.1 months), after OLR and LLR, respectively (p = 0.10). Similarly, there was not a statistically significant difference in both 3 years DFS (23.5% ± 8.1 months vs. 51.6 ± months) and 5 years DFS (15.7 ± 7.1 months vs. 38.7 ± 15.3 months), respectively (p = 0.13), despite a potential clinically significant difference.

CONCLUSION

LLR for huge HCC may be safe and effective in selected cases. Further studies with larger sample size and more appropriate design are needed to confirm these results.

摘要

背景

腹腔镜肝切除术(LLR)治疗巨大(> 10cm)肝细胞癌(HCC)的安全性和可行性仍缺乏证据。本研究旨在评估来自连续患者的真实数据中,LLR 与开腹肝切除术(OLR)治疗巨大 HCC 患者的短期和长期结果。

方法

从韩国的一家肝胆胰专科转诊中心回顾性收集所有接受巨大 HCC 肝切除术的连续患者的数据。主要结果是术后结果,次要结果是肿瘤学生存。

结果

研究纳入 63 例患者:46 例行 OLR,17 例行 LLR。关于术后结果,在估计出血量、手术时间、输血、术后胆漏、腹水、严重并发症和 R1 切除率方面,两组间无统计学差异。在中位随访 48.4(95%CI 8.9-86.8)个月后,OLR 和 LLR 组的 3 年 OS(59.3±8.7 个月 vs. 85.2±9.8 个月)和 5 年 OS(31.1±9 个月 vs. 73.1±14.1 个月)无统计学差异(p=0.10)。同样,OLR 和 LLR 组的 3 年 DFS(23.5%±8.1 个月 vs. 51.6± 个月)和 5 年 DFS(15.7±7.1 个月 vs. 38.7±15.3 个月)也无统计学差异(p=0.13),尽管存在潜在的临床显著差异。

结论

对于选择合适的病例,LLR 治疗巨大 HCC 可能是安全有效的。需要更大样本量和更合适设计的进一步研究来证实这些结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8333/11525279/3180f9fd6bb8/464_2024_11091_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验